Professor Southern is Director of the Cheshire, Merseyside and North Wales Network of Paediatric Cystic Fibrosis Care with responsibility for the care of over 300 children with CF in the North West of England. He is the Chief Investigator on the national UK CF START study, a trial funded by the UK government to evaluate the safest and most effective antibiotic treatment strategy for infants with CF. In 2007, he helped establish the national UK Newborn Screening Programme for CF and he now chairs the Board overseeing this programme. He is the Leader of the European CF Society Neonatal Screening Working Group. He is an Editor for the international Cochrane Review Group evaluating evidence for therapies for people with CF. In addition to his editorial role, he has written and contributed to 12 systematic reviews and his research is focused on translating evidence into practice. He is an elected member of the ECFS Board and, as such, has a global perspective on the issues facing people with CF.
Post-doctoral opportunities with his team include, systematic reviews of interventions for people with CF (including work on developing a core outcome set), innovative trial design and implementation, development of patient reported outcomes and developing a bioethical approach to newborn bloodspot screening.

https://www.liverpool.ac.uk/translational-medicine/staff/kevin-southern/